Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2019-001525
Request Summary: The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.
Disposition: Disclosed in part
Number of pages: 898